| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
In order to identify the molecular weight forms of bioactive and immunoactive inhibin in human plasma, plasma/serum was sequentially fractionated by immunoaffinity chromatography (using immobilised inhibin 
subunit antiserum), reversed phase HPLC and preparative SDS-PAGE. The electroeluted gel fractions were assayed for inhibin in vitro bioactivity and immunoactivity, the latter by RIA. Initial experiments examined human follicular fluid as an inhibin-rich source. Bioactive and immunoactive fractions of 30, 35, 53, 65 and 
120 kDa were identified in addition to bio-inactive, immunoactive fractions of 26 kDa and 32 kDa. These molecular weights correspond to those of known inhibin forms and are attributed to differing degrees of glycosylation of the inhibin subunit and variable processing of the and β inhibin subunits.
Fractionation of male plasma pools revealed the presence of higher molecular weight immunoactive forms (55–120 kDa) as well as 28–31 kDa forms although the molecular weight distribution of activity between pools varied. To assess if the molecular weight pattern was modified by storage and/or subsequent fractionation, protease inhibitors were added initially to plasma and fractionated as above. The molecular weight distribution of immunoactivity was largely unaffected by the treatment, indicating that minimal processing had occurred. Postmenopausal serum itself showed low to undetectable activity. The addition of recombinant human 31 kDa inhibin to postmenopausal serum resulted in a molecular weight profile of inhibin immunoactivity consistent with the presence of 31 kDa inhibin. Fractionation of a serum pool from women undergoing gonadotrophin stimulation, in which inhibin levels were elevated, showed a range of bioactive and immunoactive inhibin forms over the 30–120 kDa range. A good correspondence between activities was observed.
It is concluded that: 1. inhibin exists in plasma/serum as a range (28–120 kDa) of molecular weight forms. 2. In female serum, the majority of inhibin isoforms appear to be bioactive. 3. This fractionation procedure provides a basis for investigating the forms of inhibin in plasma and provides a means of assessing the specificity of new assay methods.
Journal of Endocrinology (1995) 144, 261–269
This article has been cited by other articles:
|
|
 |
|
  S. Tong, L. Rombauts, A. Mulder, B. Marjono, J. L. Onwude, and E. M. Wallace Increased Day 15-17 Serum Pro-{alpha}C Inhibin Levels Specific to Successful Pregnancy J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4464 - 4468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Thirunavukarasu, T. Stephenson, J. Forray, P. G. Stanton, N. Groome, E. Wallace, and D. M. Robertson Changes in Molecular Weight Forms of Inhibin A and Pro-{alpha}C in Maternal Serum during Human Pregnancy J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5794 - 5804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cariou-Guennoc, J.C. Poirier, B. Calas, A. Locatelli, J.L. Dacheux, and M.R. Blanc Evidence That Luteinizing Hormone-Releasing Hormone Statin from Ovine Rete Testis Fluid Is Immunologically Related to {alpha}C Inhibin Biol Reprod, June 1, 2000; 62(6): 1551 - 1563. [Abstract] [Full Text]
|
|
|
|
|
|
A. Sehested, A. Juul, A. M. Andersson, J. H. Petersen, T. K. Jensen, J. Müller, and N. E. Skakkebaek Serum Inhibin A and Inhibin B in Healthy Prepubertal, Pubertal, and Adolescent Girls and Adult Women: Relation to Age, Stage of Puberty, Menstrual Cycle, Follicle-Stimulating Hormone, Luteinizing Hormone, and Estradiol Levels J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1634 - 1640. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Nagaoka, Y. Nambo, N. Nagamine, S.-I. Nagata, Y. Tanaka, H. Shinbo, N. Tsunoda, H. Taniyama, G. Watanabe, N. P. Groome, et al. A selective increase in circulating inhibin and inhibin pro-alpha C at the time of ovulation in the mare Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E870 - E875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lux, L. Attisano, and D. A. Marchuk Assignment of Transforming Growth Factor beta 1 and beta 3 and a Third New Ligand to the Type I Receptor ALK-1 J. Biol. Chem., April 9, 1999; 274(15): 9984 - 9992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bläuer, S. Husgafvel, H. Syvälä, P. Tuohimaa, and T. Ylikomi Identification of a Nuclear Localization Signal in Activin/Inhibin ßA Subunit; Intranuclear ßA in Rat Spermatogenic Cells Biol Reprod, March 1, 1999; 60(3): 588 - 593. [Abstract] [Full Text]
|
|
|
|
|
|
P. M. Petersen, A.-M. Andersson, M. Rørth, G. Daugaard, and N. E. Skakkebæk Undetectable Inhibin B Serum Levels in Men after Testicular Irradiation J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 213 - 215. [Abstract] [Full Text]
|
|
|
|
|
|
A.-M. Andersson, J. Müller, and N. E. Skakkebæk Different Roles of Prepubertal and Postpubertal Germ Cells and Sertoli Cells in the Regulation of Serum Inhibin B Levels J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4451 - 4458. [Abstract] [Full Text]
|
|
|
|
|
|
A.-M. Andersson, J. Toppari, A.-M. Haavisto, J. H. Petersen, T. Simell, O. Simell, and N. E. Skakkebæk Longitudinal Reproductive Hormone Profiles in Infants: Peak of Inhibin B Levels in Infant Boys Exceeds Levels in Adult Men J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 675 - 681. [Abstract] [Full Text]
|
|
|
|
|
|
A.-M. Andersson, A. Juul, J. H. Petersen, J. Muller, N. P. Groome, and N. E. Skakkebak Serum Inhibin B in Healthy Pubertal and Adolescent Boys: Relation to Age, Stage of Puberty, and Follicle-Stimulating Hormone, Luteinizing Hormone, Testosterone, and Estradiol Levels J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 3976 - 3981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Jensen, A.-M. Andersson, N. H. I. Hjollund, T. Scheike, H. Kolstad, A. Giwercman, T. B. Henriksen, E. Ernst, J. P. Bonde, J. Olsen, et al. Inhibin B as a Serum Marker of Spermatogenesis: Correlation to Differences in Sperm Concentration and Follicle-Stimulating Hormone Levels. A Study of 349 Danish Men J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4059 - 4063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Petraglia, S. Luisi, C. Benedetto, M. Zonca, P. Florio, E. Casarosa, A. Volpe, S. Bernasconi, and A. R. Genazzani Changes of Dimeric Inhibin B Levels in Maternal Serum Throughout Healthy Gestation and in Women with Gestational Diseases J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2991 - 2995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pigny, R. Desailloud, C. Cortet-Rudelli, A. Duhamel, D. Deroubaix-Allard, A. Racadot, and D. Dewailly Serum {alpha}-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1939 - 1943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Robertson, N. Cahir, J. K. Findlay, H. G. Burger, and N. Groome The Biological and Immunological Characterization of Inhibin A and B Forms in Human Follicular Fluid and Plasma J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 889 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Aitken, E. M. Wallace, J. A. Crossley, I. A. Swanston, Y. van Pareren, M. van Maarle, N. P. Groome, J. N. Macri, and J. M. Connor Dimeric Inhibin A as a Marker for Down's Syndrome in Early Pregnancy N. Engl. J. Med., May 9, 1996; 334(19): 1231 - 1236. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
